Commonwealth Equity Services’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAM
AIM
FCM
VPM
AVM
VCM
NAMA
Commonwealth Equity Services's BEAM Position: Q1 2026 in Review
Commonwealth Equity Services sold out of Beam Therapeutics (BEAM) in Q1 2026, closing a stake of 7,495 shares — an estimated $208K sold.
Commonwealth Equity Services first reported a position in BEAM in Q4 2020 and held it in 13 quarters. The position peaked at $939K in Q2 2021. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.
- Commonwealth Equity Services reported no remaining Beam Therapeutics position as of Q1 2026 after selling out during the quarter.
- Commonwealth Equity Services sold 7,495 Beam Therapeutics shares in Q1 2026, an estimated $208K.
- Commonwealth Equity Services first reported a position in Beam Therapeutics in Q4 2020 and held it in 13 quarters.
- Commonwealth Equity Services's Beam Therapeutics position peaked at $939K in Q2 2021.
- 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.
Based on Commonwealth Equity Services's 13F filing for Q1 2026, filed 27 Apr 2026.